Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
5,710.00
-70.00 (-1.21%)
Feb 21, 2025, 9:00 AM KST
Kwang Dong Pharmaceutical Revenue
Kwang Dong Pharmaceutical had revenue of 424.59B KRW in the quarter ending September 30, 2024, with 6.72% growth. This brings the company's revenue in the last twelve months to 1.63T, up 8.23% year-over-year. In the year 2023, Kwang Dong Pharmaceutical had annual revenue of 1.51T with 5.79% growth.
Revenue (ttm)
1,634.20B
Revenue Growth
+8.23%
P/S Ratio
0.14
Revenue / Employee
1.57B
Employees
1,042
Market Cap
224.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,514.45B | 82.91B | 5.79% |
Dec 31, 2022 | 1,431.55B | 93.36B | 6.98% |
Dec 31, 2021 | 1,338.18B | 94.41B | 7.59% |
Dec 31, 2020 | 1,243.77B | 5.51B | 0.45% |
Dec 31, 2019 | 1,238.25B | 58.03B | 4.92% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
KT&G Corporation | 5,793.78B |
Amorepacific | 3,719.46B |
Samyang Foods | 1,575.91B |
LG H&H | 6,769.21B |
ORION | 3,010.89B |
CJ Cheiljedang | 29.16T |
Dong Suh Companies | 479.36B |
E-MART | 29.13T |